blogs

• 2 Aug, 2025 - 01:42 PM
• Kavya S V

Generic Medicines And How Safe Are They?

Any substance that is meant to be used in the diagnosis, treatment, alleviation, cure, or prevention of disease is considered a drug. A generic medication is the same as a brand-name medication in terms of dose form, safety, strength, mode of administration, quality, performance characteristics, and intended purpose, according to the US Food and Drug Administration (US FDA). Regulatory definitions state that generic drug products must be exactly the same as their reference in terms of quality requirements, the active ingredient, and the method of administration.

Thus, generic medications are just as safe and effective as name-brand ones. Without a patent, generic medications are made and sold. After the original branded drug's patent protections have expired, generic medications become accessible. Generic medications are deemed therapeutically similar based on basic bioequivalence testing, while innovator medications must prove their clinical efficacy and safety.

For example, Crocin, Dolo or Calpol are brand names, whereas Paracetamol is the generic term. Both relieve pain and fever, but generics are much less expensive.

This application is completely different from the new drug application. A portion of the safety and/or efficacy data for a previously approved medication may be relied upon by the applicant and regulatory authorities in this application, according to CDSCO and DCGI. However, to support new claims for an approved medicine, more clinical and/or non-clinical data are needed. The new claim determines the additional information required to assess the new generic drug's safety and effectiveness. if the medication is already marketed in significant nations and has multiple agency approvals for the proposed additional claim. if there is no change in metabolism brought on by ethnic differences and the generic medication demonstrates its pharmacological and bioequivalence with the licensed medication. If the proposed new claim relates to a disease of particular importance or a serious, life-threatening condition, the criteria for animal toxicological and clinical data may be lowered or eliminated. Before approving the production or import of such novel medications, CDSCO will assess whether the petitions are reasonable. If required, the issue may also be investigated following expert or expert committee consultation.

 

Documents Required for Generic Drug Approval:

Sl. No.	Requirements	India	USA
1	Regulatory Authority	Central Drug Standard & Control Organization (CDSCO)	United Food and Drug Administration (US FDA)
2	Application	MAA	ANDA
3	No. of Copies	1	3(Archival, Review, Field)
4	Debarment Certification	NA (Not applicable)	Required
5	Clinical Study fee	50000 Rs
6	Approval Timeline	12 months	18 months
7	Presentation	Paper	eCTD &Paper

 

To submit an abbreviated new medication application, several types of documents are necessary, as described below.

Ingredients	Raw Material	FDC Approval	Additional Approval
Bio-Availability/ Bio-equivalence	Production Method	Justification	Number and Date of Approval Already Granted
Name of Examiner/Centre	QC parameters, Specification and Stability	Pharmacokinetic/ Pharmacodynamic Data	Justification
Raw Material source and Stability	Toxicity to Animals	Any Other Data	Safety. Efficacy and Quality Data

Globally:

·       They have FDA approval in the United States.

·       Under the Essential Medicines List, WHO also endorses generic medications.

Indeed, generic medicines are safe if they have been approved by a recognized regulatory authority. They have to:

·       Have the same active component as the drug's original brand.

·       Be bioequivalent, meaning they have the same clinical effect and function similarly.

·       Observe the same safety, purity, and quality requirements.

Generic medications are equally effective in treating illnesses and controlling symptoms as their name-brand equivalents, according to a plethora of research and empirical data.

Some patients may find it difficult to follow their doctor's instructions due to the high expenses of prescription medications. In order to lessen the severity of symptoms or live with less discomfort, patients with many medical problems must continue taking their prescription medication. Patients may choose to look into generic drug alternatives rather than not filling their prescription when the expense of some prescriptions prevents them from using them consistently.

With generics, patients can save a significant amount of money.
The FDA estimates that generic medications can be up to 85% less expensive than the original medications. How is this possible? The cost of brand-name medications can be significantly reduced because studies involving their bioequivalent generic alternatives do not need to be replicated.

Choosing a Generic Equivalent Is Simple for Patients
Alternatives to many well-known brand-name medications are easily found by patients. With over 12,000 generic medications available to customers, a surprisingly high percentage of well-known medications have high-quality generic versions. For instance, Fexofenadine can be used in place of the allergy drug Allegra. Warfarin can be used in place of Coumadin, another well-known blood thinner.

Generic medications have the potential to be just as effective as their name-brand counterparts.
For patients, generic medicine substitutes provide a safe, FDA-approved option. In many aspects, such as form, dose, strength, safety, quality, intended use, and performance qualities, these medications are exactly the same as their brand-name counterparts. It is believed that the generic alternative is bioequivalent.

Keep the Course with Generics
Compared to their generic counterparts, patients are 3 times more likely to stop using branded medications, and expensive copays are frequently the reason for this discontinuation. Generic medications are a convenient and reasonably priced solution for the large number of individuals who must take prescription medications, which may improve the likelihood that patients will adhere to treatment recommendations from their doctors.

India’s Role in the Global Generic Market:

India is the world's largest provider by volume, making it a major player in the global generic medication market. It supplies 20% of the world's generic medications and is a significant supplier of reasonably priced vaccines, especially those used in underdeveloped nations. With a third-largest volume and a fourteenth-largest value, India leads the world in pharmaceuticals.

Affordable Drugs: India is a vital supplier of pharmaceuticals for developing nations due to its reputation for manufacturing high-quality, reasonably priced medications.

Largest Generic provider: India supplies a significant amount of the world's need for generic medications, making it the largest provider in the world.

API Manufacturing: India is a significant manufacturer of Active Pharmaceutical Ingredients (APIs), vital elements in drug production, and a significant contributors to the global API market.

Regulatory Compliance: India's dedication to quality and regulatory standards is evidenced by the high number of pharmaceutical manufacturing plants that have received FDA approval in the US.

Cost-effective Production: Because of things like competitive manufacturing techniques and the ability to reverse-engineer branded medications, Indian companies have been able to sell generic medications at reduced costs.

Competition: There may be more pressure on prices as a result of the growing number of companies in the generic medication market.

Generic medications are a cost-effective, safe, and practical way to combat growing medical expenses. They are used daily by millions of people worldwide, are subject to stringent regulatory inspections, and adhere to international production standards. It's critical to have faith in the research underlying them and to seek advice from licensed pharmacies and medical experts. Changing to generics can often increase treatment accessibility without sacrificing quality.

1.     Why do generic medications cost less?
Because manufacturers can avoid spending money on brand creation, promotion, and research and development.

2.     Are all drugs available in generic form?
Not all the time. It's possible that some more recent medications are still patented and do not yet have a generic equivalent.

3.     Can I switch from a branded drug to a generic?
Yes, but before making changes, always get your doctor's approval.

4.     Who approves generic medicines in India?
After confirming that generic medications fit quality, safety, and bioequivalence requirements, the Central Drugs Standard Control Organization (CDSCO) in India assesses and authorizes them.

5.     Can I trust Indian generic medicines?
Indeed, a large number of Indian pharmaceutical firms, including Cipla, Sun Pharma, Dr. Reddy's, and others, have received approval from the USFDA and WHO and export premium generic medications all over the world.

1.     Kumar P, Mangla B, Singh S, et al. Generic drug in global market and regulatory environment. Indo Am J Pharm 2017; 4: 4705–4719.

2.  Chandra, A. and Kumar, B., 2016. A comparitive study of the drug approval process in USA, India, Japan And Europe. World journal of pharmaceutical Research, 6(1), pp.311-322.

3.     Howland RH. Are generic medications safe and effective?. Journal of psychosocial nursing and mental health services. 2010 Mar 1;48(3):13-6.

4.     Peters JR, Hixon DR, Conner DP, Davit BM, Catterson DM, Parise CM. Generic drugs–safe, effective, and affordable. Dermatologic therapy. 2009 May;22(3):229-40.

5.     co.nic.in/CDSCO-GuidanceForIndustry.pdf. (Accessed 26. 05. 2023 )

6.     Gail A. Van Norman, Drugs and Devices: Comparison of European and U.S. Approval Processes, JACC: Basic to Translational Science, Volume 1, Issue 5, 2016, Pages 399-412, ISSN 2452-302X, https://doi.org/10.1016/j.jacbts.2016.06.003.

7.     Abbreviated New Drug Application (ANDA) approval process. http://fdadrugcompliance.com/resources/anda/.

8.     Dixit A, Kumar N, Kumar S. Use of generic medicines: Challenges and benefits. Journal of health management. 2018 Mar;20(1):84-90.

9.     Mathew P. Generic drugs: Review and experiences from South India. Journal of family medicine and primary care. 2015 Jul 1;4(3):319-23.

10.  Rana P, Roy V. Generic medicines: issues and relevance for global health. Fundamental & clinical pharmacology. 2015 Dec;29(6):529-42.